Five-Year Extended Hormone Therapy No Better in Breast Cancer
Findings compared with two years of extended adjuvant anastrozole in postmenopausal women with hormone-receptor-positive breast cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.